Poul Sorensen
Directeur Technique/Scientifique/R&D chez Novelix Pharmaceuticals, Inc.
Profil
Poul Sorensen is Chief Science Consultant of Novelix Pharmaceuticals, Inc. He is Director of the Tumor Genetics Laboratory and a Professor of Pathology at the University of British Columbia, and a Senior Scientist at the British Columbia Cancer Research Centre in Vancouver, Canada.
Dr. Sorensen has over 15 years experience in tumor biology and cancer drug target identification.
Postes actifs de Poul Sorensen
| Sociétés | Poste | Début |
|---|---|---|
Novelix Pharmaceuticals, Inc.
 Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Directeur Technique/Scientifique/R&D | 01/01/1995 |
| University of British Columbia | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Novelix Pharmaceuticals, Inc.
Novelix Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novelix Pharmaceuticals, Inc. is a biotechnology company. The firm manufactures pharmaceutical products. It focuses on lung, colon and dermato-oncology indications. The company was founded by Jeremy Teraoka and Burkhard Jansen in 2005 and is headquartered in Encinitas, CA. | Health Services |
